HCATNasdaq

Health Catalyst, Inc.

Alert me on HCAT

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Sep 17 Buy Kohl Simeon Insider

1 week

−3.3%S&P +0.9%

1 month

−4.2%S&P +0.3%

3 months

Result in37 trading days

6 months

Result in100 trading days

Dec 10, 2025 Sale Larson-Green Julie Insider

1 week

−9.5%S&P −2.4%

1 month

−6.8%S&P +1.4%

3 months

−50.0%S&P −3.4%

6 months

−29.9%S&P +8.5%

Dec 10, 2025 Sale Landry Benjamin Insider

1 week

−9.5%S&P −2.4%

1 month

−6.8%S&P +1.4%

3 months

−50.0%S&P −3.4%

6 months

−29.9%S&P +8.5%

Sep 10, 2025 Sale Landry Benjamin Insider

1 week

−13.8%S&P +1.1%

1 month

−14.7%S&P +3.2%

3 months

−19.9%S&P +5.0%

6 months

−45.1%S&P +2.7%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for HCAT

98 held · newest 598 held · newest 2

Loading the filings.

See all 98 filings for HCAT

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

Sep 16 Insider

Kohl Simeon (CEO) bought $105K

A week later−3.3%S&P +0.9%

A month later−4.2%S&P +0.3%

Result in 37 trading days

Result in 100 trading days

Stakes

Sep 4, 2026 Schedule 13D, amended

Palogic Value Management, LP: 7.1%, 5,374,949 shares

Jun 30, 2026 Schedule 13G, amended

CDC Financial, Inc.: 9.6%, 7,092,698 shares

Jun 30, 2026 Schedule 13G, amended

BlackRock, Inc.: 1.5%, 1,128,517 shares

Jun 30, 2026 Schedule 13G

Impax Asset Management Group plc: 5.4%, 4,000,000 shares

Jun 12, 2026 Schedule 13D

Palogic Value Management, LP: 6.7%, 4,918,866 shares

Jun 4, 2026 Schedule 13D, amended

Whetstone Capital Advisors, LLC: 4.5%, 3,285,690 shares

Mar 31, 2026 Schedule 13G, amended

CDC Financial, Inc.: 8.6%, 6,307,245 shares

Mar 13, 2026 Schedule 13G, amended

The Vanguard Group: 0%, 0 shares

Mar 12, 2026 Schedule 13D, amended

Mathew P. Arens: 18.3%, 13,465,373 shares

Feb 17, 2026 Schedule 13D, amended

Whetstone Capital Advisors, LLC: 8.2%, 5,782,941 shares

Jan 15, 2026 Schedule 13D

Whetstone Capital Advisors, LLC: 7.4%, 5,265,377 shares

Dec 31, 2025 Schedule 13G, amended

Whetstone Capital Advisors, LLC: 5.3%, 3,750,377 shares

Dec 15, 2025 Schedule 13G

CDC Financial, Inc.: 5.5%, 3,897,678 shares

Dec 1, 2025 Schedule 13D

Mathew P. Arens: 19.7%, 13,922,623 shares

Sep 30, 2025 Schedule 13G, amended

Mathew P. Arens: 19.8%, 13,969,217 shares

Jun 30, 2025 Schedule 13G

Whetstone Capital Advisors, LLC: 5.4%, 3,731,350 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.